DEXCOM INC (DXCM) is a publicly traded company in the Unknown sector. Across all available filings, 33 corporate insiders have executed 1017 transactions totaling $325.5M, demonstrating a bearish sentiment with -$323.5M in net insider flow. The most recent transaction on Nov 14, 2025 involved a sale of 2,906 shares valued at $171.6K.
No significant insider buying has been recorded for DXCM in the recent period.
No significant insider selling has been recorded for DXCM in the recent period.
Based on recent SEC filings, insider sentiment for DXCM is bearish with an Insider Alignment Score of 0/100 and a net flow of -$323.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at DEXCOM INC (DXCM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 33 insiders are actively trading DXCM stock, having executed 1017 transactions in the past 90 days. The most active insider is Kevin R. Sayer (Executive), who has made 178 transactions totaling $126.0M.
Get notified when executives and directors at DXCM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | Alexander Collins Richard | Executive | Sale | 2,906 | $59.05 | $171.6K | |
| Nov 12, 2025 | P. Heller Bridgette | Executive | Sale | 1,012 | $58.07 | $58.8K | |
| Nov 10, 2025 | Alexander Collins Richard | Executive | Sale | 3,948 | $55.17 | $217.8K | |
| Nov 10, 2025 | Steven Leach Jacob | Executive | Purchase | 15,700 | $54.98 | $863.2K | Large |
| Nov 10, 2025 | Steven Leach Jacob | Executive | Purchase | 2,500 | $55.43 | $138.6K | |
| Oct 24, 2025 | A. Ashley Euan | Executive | Award | 7,166 | $N/A | $0 | |
| Sep 5, 2025 | Malady Kyle | Executive | Sale | 667 | $80.86 | $53.9K | |
| Sep 4, 2025 | Stern Sadie | Executive | Sale | 1,466 | $80.00 | $117.3K | |
| Sep 2, 2025 | M. Sylvain Jereme | Executive | Sale | 4,824 | $74.17 | $357.8K | |
| Aug 15, 2025 | G. Foletta Mark | Executive | Sale | 2,555 | $81.02 | $207.0K | |
| Aug 15, 2025 | G. Foletta Mark | Executive | Sale | 195 | $81.54 | $15.9K | |
| Aug 15, 2025 | Jon Brown Michael | Executive | Sale | 500 | $80.29 | $40.1K | |
| Jul 28, 2025 | Stern Sadie | Executive | Sale | 1,466 | $88.99 | $130.5K | |
| Jul 15, 2025 | Jon Brown Michael | Executive | Sale | 500 | $86.03 | $43.0K | |
| Jul 15, 2025 | G. Foletta Mark | Executive | Sale | 2,742 | $85.17 | $233.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 715 | $324.5M | 89.6% |
Disposition(D) | 85 | $36.2M | 10.0% |
Purchase(P) | 2 | $1.0M | 0.3% |
Award(A) | 115 | $402.0K | 0.1% |
Gift(G) | 46 | $0 | 0.0% |
Other(J) | 54 | $0 | 0.0% |
Insider selling pressure at DEXCOM INC has increased, with 33 insiders executing 1017 transactions across all time. Total sales of $324.5M significantly outpace purchases of $1.0M, resulting in a net outflow of $323.5M. This selling activity appears largely discretionary, which may warrant closer attention from investors.